Medical Device | October 11, 2021
Kaneka Covid-19 kits detect all four variants simultaneously
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
The company will shift 100 percent of its energy use to renewable sources for both power and heat by 2025 in order to achieve carbon neutrality
Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis (EoE)
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
The company plans to expand its portfolio in regulated markets aggressively
RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
The rates for over 400 procedures were revised
The transaction is anticipated to close in the first quarter of 2022
Subscribe To Our Newsletter & Stay Updated
